Assessment of the metabolic pathways associated with glucose-stimulated biphasic insulin secretion

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1653-1666

  Huang, Mei ^a   Joseph, Jamie W ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; 4 AMINOBUTYRIC ACID; BIPHASIC INSULIN; CHOLESTEROL; DECANOIC ACID; FLAVINE ADENINE NUCLEOTIDE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HYDROXYPROLINE; INOSITOL; LINOLEIC ACID; LYSINE; MYRISTIC ACID; NORLEUCINE; OCTANOIC ACID; OLEIC ACID; PALMITOLEIC ACID; PROLINE; SARCOSINE; SUCCINIC ACID; THYMINE; TRICARBOXYLIC ACID; URIDINE PHOSPHATE; VALINE;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; GLYCOLYSIS; INSULIN RELEASE; MASS FRAGMENTOGRAPHY; METABOLIC REGULATION; METABOLISM; METABOLOMICS; NONHUMAN; PANCREAS ISLET BETA CELL; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; CITRIC ACID CYCLE; CLONE CELLS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE; GLYCOLYSIS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; KINETICS; MALE; METABOLOME; OSMOLAR CONCENTRATION; PENTOSE PHOSPHATE PATHWAY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

EID: 84899441075     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1805     Document Type: Article

References (64)

1. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes. 2002;51(Suppl 1):S117-S121.
2. Cerasi E. Mechanisms of glucose stimulated insulin secretion in health and in diabetes: some re-evaluations and proposals. Diabetologia. 1975;11:1-13.
3. Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M. A novel hyperglycaemic clamp for characterization of islet functionin humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest. 2000; 30:411-418.
4. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37: 413-420.
5. Takei S, Teruya M, Grunewald A, Garcia R, Chan EK, Charles MA. Isolation and function of human and pig islets. Pancreas. 1994;9: 150-156.
6. Bertuzzi F, Saccomanno K, Socci C, et al. Long-term in vitro exposure to high glucose increases proinsulin-like-molecules release by isolated human islets. J Endocrinol. 1998;158:205-211.
7. Steiner KE, Mouton SM, Bowles CR, Williams PE, Cherrington AD. The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog. Diabetes. 1982;31:964-972.
8. Steiner KE, Mouton SM, Williams PE, Lacy WW, Cherrington AD. Relative importance of first- and second-phase insulin secretion inglucose homeostasis in conscious dog. II. Effects on gluconeogenesis. Diabetes. 1986;35:776-784.
9. Luzi L, DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol. 1989;257(2 Pt 1):E241-E246.
10. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes. 2002;51(Suppl 1):S109-S116.
11. Prentki M, Matschinsky FM. Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev. 1987;67:1185-1248.
12. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol. 1989;54:87-143.
13. Henquin JC, Ravier MA, Nenquin M, Jonas JC, Gilon P. Hierarchy of the β-cell signals controlling insulin secretion. Eur J Clin Invest. 2003;33:742-750.
14. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2008;295: E1287-E1297.
15. Shiota C, Larsson O, Shelton KD, et al. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem. 2002;277:37176-37183.
16. NenquinM,Szollosi A, Aguilar-Bryan L, Bryan J, Henquin JC. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic β-cells. J Biol Chem. 2004;279:32316-32324.
17. Ravier MA, Nenquin M, Miki T, Seino S, Henquin JC. Glucose controls cytosolic Ca2+and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K+channels owing to a knockout of the pore-forming subunit Kir6.2. Endocrinology. 2009;150:33-45.
18. Joseph JW, Odegaard ML, Ronnebaum SM, et al. Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion. J Biol Chem. 2007;282: 31592-31600.
19. Lu D, Mulder H, Zhao P, et al. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci USA. 2002;99: 2708-2713.
20. Deeney JT, Prentki M, Corkey BE. Metabolic control ofβ-cell function. Semin Cell Dev Biol. 2000;11:267-275.
21. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem. 1992;267:5802-5810.
22. Ronnebaum SM, Ilkayeva O, Burgess SC, et al. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem. 2006;281:30593-30602.
23. Joseph JW, Jensen MV, Ilkayeva O, et al. The mitochondrial citrate/ isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J Biol Chem. 2006;281:35624-35632.
24. Cerasi E, Luft R, Efendic S. Decreased sensitivity of the pancreaticβ cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes. 1972;21:224-234.
25. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB. Isolation of INS-1-derived cell lines with robust ATPsensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes. 2000;49:424-430.
26. Huypens P, Pillai R, Sheinin T, et al. The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreaticβ cells. Diabetologia. 2011;54:135-145.
27. Pillai R, Huypens P, Huang M, et al. Aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor-1β plays a critical role in maintaining glucose-stimulated anaplerosis and insulin release from pancreatic β-cells. J Biol Chem. 2011;286:1014-1024.
28. Henquin JC, Nenquin M, Ravier MA, Szollosi A. Shortcomings of current models of glucose-induced insulin secretion. Diabetes Obes Metab. 2009;11(Suppl 4):168-179.
29. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6:469-479.
30. Wiklund S, Johansson E, Sjöström L, et al. Visualization of GC/ TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem. 2008;80:115-122.
31. Halestrap AP. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J. 1975;148:85-96.
32. Halestrap AP. The mechanism of the inhibition of the mitochondrial pyruvate transportater by α-cyanocinnamate derivatives. Biochem J. 1976;156:181-183.
33. Spégel P, Sharoyko VV, Goehring I, et al. Time-resolved metabolomics analysis ofβ-cells implicates the pentose phosphate pathway in the control of insulin release. Biochem J. 2013;450:595-605.
34. LorenzMA,El AzzounyMA,KennedyRT,Burant CF. Metabolome response to glucose in the β-cell line INS-1 832/13. J Biol Chem. 2013;288:10923-10935.
35. Huang M, Joseph JW. Metabolomic analysis of pancreatic β-cell insulin release in response to glucose. Islets. 2012;4:210-222.
36. Hasan NM, Longacre MJ, Stoker SW, et al. Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase. J Biol Chem. 2008;283:28048-28059.
37. MacDonald MJ, Stoker SW, Hasan NM. Anaplerosis from glucose, α-ketoisocaproate, and pyruvate in pancreatic islets, INS-1 cells and liver mitochondria. Mol Cell Biochem. 2008;313:195-202.
38. MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA. Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am J Physiol Endocrinol Metab. 2005;288:E1-E15.
39. Maechler P, Antinozzi PA, Wollheim CB. Modulation of glutamate generation in mitochondria affects hormone secretion in INS-1E β cells. IUBMB Life. 2000;50:27-31.
40. Meredith M, Rabaglia ME, Metz SA. Evidence of a role for GTP in the potentiation of Ca(2+)-induced insulin secretion by glucose in intact rat islets. J Clin Invest. 1995;96:811-821.
41. Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentki M. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic β-cells. J Biol Chem. 1989;264: 21608-21612.
42. Newgard CB, Lu D, Jensen MV, et al. Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach. Diabetes. 2002;51(Suppl 3):S389-S393.
43. Broca C, Brennan L, Petit P, Newsholme P, Maechler P. Mitochondria-derived glutamate at the interplay between branched-chain amino acid and glucose-induced insulin secretion. FEBS Lett. 2003; 545:167-172.
44. Ivarsson R, Quintens R, Dejonghe S, et al. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes. 2005;54:2132-2142.
45. Kibbey RG, Pongratz RL, Romanelli AJ, Wollheim CB, Cline GW, Shulman GI. Mitochondrial GTP regulates glucose-stimulated insulin secretion. Cell Metab. 2007;5:253-264.
46. Schuit F, De Vos A, Farfari S, et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in β cells. J Biol Chem. 1997;272:18572-18579.
47. Khan A, Ling ZC, Landau BR. Quantifying the carboxylation of pyruvate in pancreatic islets. J Biol Chem. 1996;271:2539-2542.
48. MacDonald MJ. Estimates of glycolysis, pyruvate (de)carboxylation, pentose phosphate pathway, and methyl succinate metabolism in incapacitated pancreatic islets. Arch Biochem Biophys. 1993; 305:205-214.
49. Odegaard ML, Joseph JW, Jensen MV, et al. The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion. J Biol Chem. 2010;285:16530-16537.
50. MacDonald PE, Joseph JW, Rorsman P. Glucose-sensing mechanisms in pancreatic β-cells. Philos Trans R Soc Lond B Biol Sci. 2005;360:2211-2225.
51. Huypens PR, Huang M, Joseph JW. Overcoming the spatial barriers of the stimulus secretion cascade in pancreatic β-cells. Islets. 2012; 4:1-9.
52. Verspohl EJ, Handel M, Ammon HP. Pentosephosphate shunt activity of rat pancreatic islets: its dependence on glucose concentration. Endocrinology. 1979;105:1269-1274.
53. Ammon HP, Patel TN, Steinke J. The role of the pentose phosphate shunt in glucose induced insulin release: in vitro studies with 6-aminonicotinamide, methylene blue, NAD+, NADH, NADP+, NADPH and nicotinamide on isolated pancreatic rat islets. Biochim Biophys Acta. 1973;297:352-367.
54. Oliveira HR, Curi R, Carpinelli AR. Glucose induces an acute increase of superoxide dismutase activity in incubated rat pancreatic islets. Am J Physiol. 1999;276:C507-C510.
55. Giroix MH,Sener A, Malaisse WJ. Pentose cycle pathway in normal and tumoral islet cells. FEBS Lett. 1985;185:1-3.
56. MacDonald MJ. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolicNADPH in insulin secretion. J Biol Chem. 1995;270:20051-20058.
57. Fernandez C, Fransson U, Hallgard E, et al. Metabolomic and proteomic analysis of a clonal insulin-producing β-cell line (INS-1 832/ 13). J Proteome Res. 2008;7:400-411.
58. Zraika S, Dunlop M, Proietto J, Andrikopoulos S. The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys. 2002;405:275-279.
59. Nolan CJ, PrentkiM.The isletβ-cell: fuel responsive and vulnerable. Trends Endocrinol Metab. 2008;19:285-291.
60. Nolan CJ, Madiraju MS, ghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the β-cell and insulin secretion. Diabetes. 2006;55(Suppl 2):S16-S23.
61. Mulder H, Lu D, Finley J, et al. Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS- 1-derived (832/13) β-cells. J Biol Chem. 2001;276:6479-6484.
62. Roduit R, Nolan C, Alarcon C, et al. A role for the malonyl-CoA/ long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes. 2004;53:1007-1019.
63. MacDonald MJ, Smith AD 3rd, Hasan NM, Sabat G, Fahien LA. Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic β cell. J Biol Chem. 2007;282:30596-30606.
64. Macdonald MJ, Hasan NM, Longacre MJ. Studies with leucine, β-hydroxybutyrate and ATP citrate lyase-deficient β cells support the acetoacetate pathway of insulin secretion. Biochim Biophys Acta. 2008;1780:966-972. of Canada